Moxonidine Teva Sante

Moxonidine, the active ingredient in Moxonidine Teva Sante, is a Imidazoline receptor agonist presented as an oral dosage form for Oral use. It is used to lower elevated blood pressure in adults with hypertension. GNH USA supplies Moxonidine Teva Sante as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxonidine belongs to the imidazoline receptor agonist class and is employed in the management of high blood pressure. - Essential hypertension: lowers systolic and diastolic blood pressure in adults with primary hypertension. - Resistant hypertension: provides additional pressure reduction when used with other antihypertensive agents. - Isolated systolic hypertension: helps control elevated systolic pressure, particularly in older patients.

Moxonidine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dry mouth: sensation of oral dryness without obvious cause. - Fatigue: feeling of tiredness or lack of energy. - Dizziness: light‑headedness, especially when standing quickly. - Headache: mild to moderate cranial pain. - Nausea: upset stomach with urge to vomit. - Constipation: infrequent, hard stools.

Serious or Rare Side Effects: - Severe hypotension: markedly low blood pressure that may cause fainting. - Bradycardia: unusually slow heart rate requiring medical attention. - Allergic reactions: rash, itching, swelling, or difficulty breathing. - Liver dysfunction: abnormal liver enzymes or jaundice. - Cardiac arrhythmia: irregular heart rhythm that can be life‑threatening.

Before initiating therapy, clinicians should evaluate individual risk factors and monitor patients for safety concerns. - Blood pressure monitoring: check regularly to avoid excessive hypotension. - Renal impairment: adjust dose or use with caution in patients with reduced kidney function. - Hepatic dysfunction: consider liver status, as metabolism may be affected. - Elderly patients: start at lower dose and titrate slowly due to increased sensitivity. - Discontinuation: avoid abrupt withdrawal; taper under medical supervision. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Moxonidine can interact with several drug classes, influencing blood pressure control or safety.

Major Interactions (Avoid): - Combined with other antihypertensives (e.g., ACE inhibitors, ARBs, diuretics): may cause additive hypotensive effects. - Clonidine or other central sympatholytics: risk of profound blood pressure drop. - MAO inhibitors: potential for severe hypertension rebound on abrupt discontinuation.

Moderate Interactions (Monitor Closely):\n- NSAIDs: may blunt antihypertensive response. - Beta‑blockers: additive heart‑rate slowing. - Alcohol: can enhance dizziness and hypotension. - Diuretics: may increase risk of electrolyte imbalance and low blood pressure.